OHF Global Registry Initiative supports clinicians and scientists developing international patient registries to understand factors shaping primary hyperoxaluria manifestations and prognosis.
Research Grants - Oxalosis and Hyperoxaluria Foundation support new and established investigators studying hyperoxaluria’s causes and treatment to advance diagnostics, therapies, and a cure.
Short-term Travel Grant supports postdoctoral and mid-career researchers with external laboratory training to strengthen research on hyperoxaluria and its treatment and improve home-institution research standards.
PFF Registry Ancillary Studies supports clinical and translational investigators with Registry data, biosamples, and scans to study pulmonary fibrosis and interstitial lung disease and improve care.
Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.